<PAGE>

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549


                                   FORM 10-QSB

[X]     Quarterly  Report  pursuant  to  Section  13  or 15(d) of the Securities
        Exchange  Act  of  1934

        For  the  quarterly  period  ended  June  30,  2002

[ ]     Transition Report pursuant to 13 or 15(d) of the Securities Exchange Act
        of  1934

        For  the  transition  period  from          to

Commission  File  Number  001-14297
                          ---------

                                MW Medical, Inc.
                                ----------------
        (Exact name of Small Business Issuer as specified in its charter)

Nevada                                           86-0907471
-------------------------------                  ----------
(State or other jurisdiction of                  (IRS Employer
 incorporation)                                  Identification No.)

                 6929 E. Cheney, Paradise Valley, Arizona 85253
                 ----------------------------------------------
                    (Address of principal executive offices)

                                 (480) 315-8600
                                 --------------
                 Issuer's telephone number, including area code


State the number of shares outstanding of each of the issuer's classes of common
equity,  as  of  the  last  practicable  date.

        Class               Outstanding as June 30, 2002
----------------------      ----------------------------
$.001 par value
Class A Common Stock                24,517,443 shares

Transitional  Small  Business Disclosure Format (Check one): Yes [   ] No [ X  ]


<PAGE>

                         PART I - FINANCIAL INFORMATION

Item  1.      Financial  Statements.

BASIS  OF  PRESENTATION

General

The accompanying unaudited financial statements have been prepared in accordance
with  the  instructions  to  Form  10-QSB  and,  therefore,  do  not include all
information  and  footnotes  necessary  for a complete presentation of financial
position,  results  of  operations,  cash  flows, and stockholders' (deficit) in
conformity  with  generally  accepted  accounting  principles. In the opinion of
management,  all adjustments considered necessary for a fair presentation of the
results  of  operations  and  financial position have been included and all such
adjustments  are  of  a  normal  recurring nature. Operating results for the six
months  ended  June 30, 2002, are not necessarily indicative of the results that
can  be  expected  for  the  year  ending  December  31,  2002


                                       2

<PAGE>


                                MW Medical, Inc.

                           CONSOLIDATED BALANCE SHEETS

                                              (Unaudited)        (Audited)
                                                June 30,       December 31,
                                                  2002             2001
                                             ------------      ------------
CURRENT ASSETS
  Cash                                       $       218       $       209
  Accounts Receivable                                                    -
  Inventory                                      300,000           300,000
  Other current assets
                                             ------------      ------------

      Total current assets                       300,218           300,209

INVENTORY, long-term

PROPERTY AND EQUIPMENT, net of allowance          36,574            55,928
  for depreciation of $336,948 and $317,544
OTHER RECEIVABLES, net                                                   -
                                             ------------      ------------


                                             $   336,792       $   356,137
                                             ============      ============

    LIABILITIES AND STOCKHOLDERS' (DEFICIT)

CURRENT LIABILITIES
  Accounts payable                           $   265,217       $   241,617
  Accrued expenses                               679,390           510,867
  Note payable - related party                   685,256           615,871
                                             ------------      ------------

      Total current liabilities                1,629,863         1,368,355

COMMITMENTS AND CONTINGENCIES                          -                 -

STOCKHOLDERS' (DEFICIT)
  Common stock $.001 par value;
  authorized - 100,000,000
    shares issued and outstanding,
    24,517,443                                    24,517            24,517
  Additional paid-in capital                  13,687,857        13,687,857
  Note receivable from former parent
  Accumulated deficit                        (15,005,445)      (14,724,592)
                                             ------------      ------------

      Total stockholders' (deficit)           (1,293,071)       (1,012,218)
                                             ------------      ------------

                                             $    336,792      $   356,137




                                       3

<PAGE>


<TABLE>
<CAPTION>

                                MW Medical, Inc.

                      CONSOLIDATED STATEMENTS OF OPERATIONS
                                At June 30, 2002
                                   (Unaudited)



                                            Three months ended June 30,  Six months ended June 30,
                                                2002          2001           2002          2001
                                            -----------  --------------------------  -------------
<S>                                         <C>          <C>           <C>           <C>
Sales, net                                           -   $    59,500   $         -   $   169,560
Cost of sales                                        -         9,737             -        80,793
                                            -----------  --------------------------  -------------

                                                     -        49,763             -        88,767

General and administrative expenses            109,901       211,598       226,907       430,999
Depreciation and amortization                    9,677        36,849        19,354        73,827
Research and development                                      73,106         1,000       200,040
                                            -----------  --------------------------  -------------


         Total operating expenses              119,578       321,553       247,261       704,866

         Net operating loss                   (119,578)     (271,790)     (247,261)     (616,099)


  Interest income                                    -
Interest income (expense)                      (18,049)     (632,632)      (33,591)     (846,701)
                                            -----------  --------------------------  -------------


                                               (18,049)     (632,632)      (33,591)     (846,701)

Loss from continuing operations
  before income taxes                         (137,627)     (904,422)     (280,852)   (1,462,800)
Income tax expense                                   -             -             -
                                            -----------  --------------------------  -------------



          NET LOSS                            (137,627)     (904,422)     (280,852)   (1,462,800)
                                            ===========  ==========================  =============


Net loss per weighted average share             ($0.01)       ($0.04)       ($0.01)       ($0.07)
                                            ===========  ==========================  =============


Weighted average number of common shares
 used to compute net loss per weighted
 average share                              24,517,443    22,517,443    24,517,443    21,904,943
                                            -----------  --------------------------  -------------



</TABLE>



                                       4


<PAGE>


<TABLE>
<CAPTION>

                                MW Medical, Inc.

                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                At June 30, 2002
                                   (Unaudited)



                                                                       Six months ended June 30
                                                                          2002         2001
                                                                       ----------- ------------
<S>                                                                    <C>         <C>
Cash flows from operating activities
  Net Loss                                                             $(280,852)  $(1,462,800)
  Adjustments to reconcile net loss to cash used in
    operating activities:
      Depreciation and amortization                                       19,354        73,827
      Deferred Salaries                                                  171,630             -
      Expenses paid in stock                                                             5,500
      Interest expense                                                    33,591       846,701
      Changes in assets and liabilities
        Increase in accounts receivable                                                 26,984
        Decrease (increase) in inventories                                             236,338
        Decrease (increase) in restricted cash                                 -
        Decrease (increase) in prepaid expenses and other receivables                  (13,747)
        Increase in accounts payable and accrued expenses                 24,536       (72,546)
        Increase in deposits                                                   -
        Decrease in income taxes payable                                       -
                                                                       ----------- ------------

          Net cash used in operating activities                          (31,741)     (359,743)
                                                                       ----------- ------------

Cash flows used in investing activities
  Purchase of equipment                                                        -

</TABLE>


                                        5

<PAGE>

<TABLE>
<CAPTION>

                                MW Medical, Inc.

                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                           At June 30, 2002- Continued
                                   (Unaudited)

                                                       Six months ended June 30,
                                                           2002        2001
                                                       ------------ -----------
<S>                                                    <C>          <C>
Cash flows from financing activities
  Capital contribution from former parent                         -         -
  Proceeds from convertible debenture offering                    -         -
  Proceeds from line of credit                                    -         -
  Proceeds from loans                                        31,750   350,100
  Payments on loans                                               -         -
  Proceeds from the exercise of stock options                     -         -
  Sale of common stock                                            -
                                                       ------------ -----------

          Net cash provided by financing activities          31,750   350,100
                                                       ------------ -----------

          (Decrease) increase in cash and cash
            equivalents                                           9    (9,643)

Cash and cash equivalents at beginning of period                209     9,825
                                                       ------------ -----------

Cash and cash equivalents at end of period             $        218 $     182
                                                       ============ ===========

Supplemental information
  Cash paid for interest                               $          -
  Cash paid for income taxes                                        $   2,400

</TABLE>


                                       6

<PAGE>


                                MW Medical, Inc.

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

                            June 30, 2002 (Unaudited)


NOTE  A  -  SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES

Basis  of  presentation
-----------------------

The  accompanying  consolidated  financial  statements  have  been  prepared  in
accordance  with  generally  accepted accounting principles ("GAAP") for interim
financial information and with the instructions to Form 10QSB. Accordingly, they
do  not  include  all  of  the  information  and footnotes required by generally
accepted  auditing  principles  for complete financial statements. The unaudited
consolidated  financial  statements  and  notes  should,  therefore,  be read in
conjunction with the financial statements and notes thereto in the Annual Report
on  Form  10-KSB  for  the  year  ended  December  31,  2001.  In the opinion of
management,  all  adjustments  (consisting  of normal and recurring adjustments)
considered  necessary  for a fair presentation, have been included.  The results
of  operations  for the six-month period ended June 30, 2002 are not necessarily
indicative  of the results that may be expected for the entire fiscal year 2002.


NOTE  B  -  REALIZATION  OF  ASSETS

The  Company  has suffered recurring losses from operations and will continue to
incur losses for the foreseeable future due to the significant costs anticipated
to  be incurred in connection with manufacturing, marketing and distributing its
microwave  products.  In  addition,  the  Company intends to continue to conduct
research  and  development  activities,  including  regulatory  submittals  and
clinical  trials  to  develop  additional  applications  for its technology. The
Company  operates  in  a highly competitive environment and is subject to all of
the  risks  inherent  in  a  new  business  enterprise.

In view of the matters described in the preceding paragraph, recoverability of a
major  portion  of  the recorded asset amounts shown in the accompanying balance
sheet  is  dependent  upon continued operations of the Company, which in turn is
dependent  upon  the  Company's  ability to meet its financing requirements on a
continuing  basis,  to  maintain present financing, and to succeed in its future
operations.  The financial statements do not include any adjustments relating to
the  recoverability  and classification of recorded asset amounts or amounts and
classification  of  liabilities  that  might  be necessary should the Company be
unable  to  continue  in  existence.


                                       7

<PAGE>

                                MW Medical, Inc.

             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - CONTINUED

                            June 30, 2002 (Unaudited)


NOTE  B  -  REALIZATION  OF  ASSETS  -  Continued


Management  has  taken  the following steps, which it believes are sufficient to
provide  the  Company  with the ability to continue its operations over the near
term:  The Company has reduced staffing to key personnel, specifically corporate
officers  and  technicians  necessary  to  continue  manufacturing  operations.
Additionally,  all  officers  are voluntarily participating in a salary deferral
program  until  additional  funding  is  secured.  The  Company  has stopped the
manufacturing  of  all  its  systems until new funding can be secured. While the
Company  has  been  successful  in negotiating payment terms with a few vendors,
formal  agreements  have  not been established with all of the vendors and there
can  be no guarantee such agreements will ever be reached.  Sales of the MW 2000
has  been  unsuccessful  in this current year partially because we are unable to
service  machines  outside  the  immediate geographical areas due to the lack of
funding  for technical staff. The Company is pursuing opportunities to establish
a  strategic  alliance  with an established entity or to possibly be acquired or
merged with another entity.  However, there can be no assurance that the Company
will  be  able to complete any contemplated alliance, merger or sale transaction
within  the  required  time  frame.


                                       8

<PAGE>

Item  2.     Management's  Discussion  and  Analysis  of Financial Condition and
Results  of  Operations.

As  of January 22, 2002, we have filed a Petition for relief under Chapter 11 of
the  Bankruptcy  Code.  An  automatic  stay  is  now in place.  We will use this
bankruptcy  to  protect  the business from our creditors while we reorganize and
try  to  work  out  a  plan  to pay our debts.  The Petition was filed in United
States  Bankruptcy Court, District of Arizona, In Re: MW MEDICAL, INC., a Nevada
Corporation,  Case  No.  02-0108-90-PHX-RTB,  and  In  Re:  MICROWAVE  MEDICAL
CORPORATION,  a California Corporation, Case No. 02-01298-PHX-GBN.  The location
of  the  United  States  Trustee  is 2929 N. Central Avenue, Suite 700, P.O. Box
36170,  Phoenix,  Arizona  85067-6170,  (602)  640-2100.

In  the  past year, sales have been slower than anticipated.  Our small revenues
have  been greatly outpaced by our operating expenses, and we are now insolvent.
With  the  economic  downturn, our unproven ability to generate revenues and the
economic  fallout  from the events of September 11, 2001, we have been unable to
raise additional capital.  Our secured creditor has determined that the value of
the  collateral  and  the  growing unsecured debt made it unlikely that we could
raise  additional  capital.  Without  any  further  loans available, and with no
prospect of raising additional capital in the face of our current balance sheet,
we  are unable to continue in business without the aid of Chapter 11 protection.
Even  with the protection afforded by the bankruptcy petition, we cannot provide
investors  with  any  assurance  we  will  emerge  from  bankruptcy  as a viable
business.

There  are  no  assets  to  be  distributed  to creditors or shareholders as the
secured  creditor  has  a  lien  on all assets and is undersecured.  The primary
objective  of  this  reorganization  is  to  allow  us to go forward as a public
company  free  of  all  debt  and  with  a  reduced secured debt.  The plan also
provides for payment to unsecured creditors of more than they would receive in a
liquidation.  We  can then seek business opportunities for a reverse merger that
will  allow  creditors and shareholders to realize value not otherwise available
to  them.  In  the  event  of  an inability to raise capital and the loss of its
assets,  we will still have the capacity to seek a reverse merger partner but we
cannot  assure  investors  a  reverse  merger  partner  will  be  found.

Since  the  filing  of the Bankruptcy, the company has not been actively selling
any machines. The Company submitted to the Debtors, the First Amended Joint Plan
of  Reorganization  on  February  21,  2002  and  all ballots were collected and
accepted  on  May  22,  2002.



Assets

Total assets decreased to $ 336,792 on June 30, 2002 from $356,137 from December
31, 2001, a decrease of $19,345 or 5.4%.  The net change resulted primarily from
a  decrease  in  the  value  of  our  equipment.

Liabilities  And  Stockholders'  Equity

Our  liabilities  increased  by  $261,508,  or 19% to $ 1,629,863 as of June 30,
2002.  The increase in liabilities was caused by unpaid salary and notes payable
-  related  party.  All  cost  involved  in the filing of the bankruptcy and the
continued  operations  of  the Company is still being funded by


                                       9

<PAGE>

Ms.  Wallace,  our  president  and  chief  executive  officer. These amounts are
reflected  in  notes  payable  - related party. The officers of the company have
elected  to  defer  all  of  their salaries. Stockholders' equity decreased to a
deficit  of  $1,293,071 from $1,012,218 as of December 31, 2001. The decrease in
stockholders'  equity  resulted  from  the continued net losses from operations.


Results  of  Operations



Due  to  the  lack of funding and the filing of Chapter 11, Bankruptcy code, the
operations  of  the Company have consisted of planning for the reorganization of
the  Company

Net  operating  loss  for  the  three  months  ended  June 30, 2002 was $119,578
compared to $271,790 on June 30, 2001.  This decrease in the net loss was caused
by  our  scaling back of operations, including a reduction in employees, closing
of  certain  clinical  sites,  and a slow down in research and development work.

General  and  administrative  expenses  for the three months ended June 30, 2002
were  $109,901 compared to $211,598 for the same period in 2001. This reflects a
decrease  of  $101,697  or  48%.  This decrease was primarily due to significant
reductions  in  staff  and  all  operating  expenses.

Research  and  development  expenses were $0 for the three months ended June 30,
2002  compared to $73,106 for the same period in 2001. The decrease reflects the
cessation of all clinical sites and research into new microwave applications for
our  proprietary  technologies.

Depreciation  and amortization expenses for the three months ended June 30, 2002
were  $9,677  compared  to  $36,849  for  the  same period in 2001. In 2001, the
Company  wrote  down the value of its inventory.  We also wrote off the value of
all  machines  used  in  the  clinical  sites  for  research  and  development.

Liquidity  and  Capital  Resources

With the exception of new loans advanced by Ms. Wallace, the Company has no cash
resources  to  sustain operations.  While limited funds have been generated from
revenues,  it  is  unlikely cash generated from operations will be sufficient to
continue  operations.

For  the  first  half  of  2002,  we  have  relied upon Ms. Wallace to providing
funding.  In  fact,  Ms.  Wallace funded all operations since November 2000.  We
have  not  yet  identified  new  sources  for  financing and we are currently in
default  on  our  notes  to  Ms.  Wallace.

As  of  June  30,  2002,  the  Company  had  $218  in  cash.

We used cash of $31,741 in our operating activities during the six months ending
June  30,  2002  compared  to $359,743 for the same period in 2001. In the first
half of 2002, we were primarily involved in procedures for the bankruptcy and in
researching the possiblity of an acquistion or a merger with another entity. The
Company  did  not  have  any  funds  for  operations.


                                       10

<PAGE>

Forward-Looking  Statements

Many  statements made in this report are forward-looking statements that are not
based  on  historical  facts.  Because  these forward-looking statements involve
risks  and  uncertainties,  there  are important factors that could cause actual
results  to  differ  materially  from  those  expressed  or  implied  by  these
forward-looking  statements.  The forward-looking statements made in this report
relate  only  to  events  as  of  the  date  on  which  the statements are made.


                                       11

<PAGE>

                           PART II - OTHER INFORMATION


Item  1.     Legal  Proceedings:

None

Item  2.     Changes  in  Securities  and  Use  of  Proceeds:

None

Item  3.     Defaults  Upon  Senior  Securities:

None

Item  4.     Submission  of  Matters  to  a  Vote  of  Security  Holders:

None

Item  5.     Other  Information:

None

Item  6.     Exhibits  and  Reports  on  Form  8-K:

            (a)     Exhibits
None
            (b)     Reports  on  Form  8-K

None


                                       12

<PAGE>

SIGNATURES

In  accordance  with  the  requirements  of the Exchange Act, the registrant has
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.


                                       MW Medical, Inc.


DATED:  August 19, 2002                /s/ Jan Wallace
                                       ____________________________________
                                       Jan Wallace, Chief Executive Officer


                                       13

<PAGE>

      CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I, Jan Wallace, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to  Section  906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on
Form  10-QSB  of  MW  Medical for the quarterly period ended June 30, 2002 fully
complies  with  the  requirements  of  Section  13(a) or 15(d) of the Securities
Exchange  Act of 1934 and that the information contained in the Quarterly Report
on  Form 10-QSB fairly presents in all material respects the financial condition
and  results  of  operations  of  MW  Medical.


                                       By:      /s/ Jan Wallace
                                                --------------------------------

                                       Name:    Jan Wallace

                                       Title:   Chief Executive Officer

                                       Date:    August 19, 2002



I,  Grace  Sim, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to  Section  906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on
Form  10-QSB  of  MW  Medical for the quarterly period ended June 30, 2002 fully
complies  with  the  requirements  of  Section  13(a) or 15(d) of the Securities
Exchange  Act of 1934 and that the information contained in the Quarterly Report
on  Form 10-QSB fairly presents in all material respects the financial condition
and  results  of  operations  of  MW  Medical.

                                       By:      /s/ Grace Sim
                                                --------------------------------

                                       Name:    Grace Sim

                                       Title:   Acting Chief Financial Officer

                                       Date:    August 19, 2002